Indeed, the disruption of this axis can lead to uncontrolled NF-κB activation, which is a hallmark of many types of cancer, such as liver, colorectal, breast, gastric, and pancreatic cancer [76], making it a potential target for therapeutic intervention. The gene discussed is NFKB1; the disease is cancer.